Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome

Journal of Oral Pathology and Medicine

Volumn 42, Issue 4, 2013, Pages 295-301

  López Jornet, Pia ^a   Camacho Alonso, Fabio ^a   Molino Pagan, Diana ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Aloe vera; Efficacy; Pain; Quality of life; Topical treatment

Indexed keywords

ALOE BARBADENSIS EXTRACT; PLACEBO;

ADULT; AGED; ANXIETY; ARTICLE; BURNING MOUTH SYNDROME; BURNING SENSATION; CLINICAL EVALUATION; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH PAIN; PAIN ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMUNERATION; VISUAL ANALOG SCALE; VITAMIN BLOOD LEVEL;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ALOE; ANXIETY; BURNING MOUTH SYNDROME; DEPRESSION; DISABLED PERSONS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTH PROTECTORS; ORAL HEALTH; PAIN MEASUREMENT; PATIENT SATISFACTION; PHYTOTHERAPY; PLACEBOS; PLANT PREPARATIONS; PROSPECTIVE STUDIES; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; TONGUE;

EID: 84875805359     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12002     Document Type: Article

References (38)

1. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275-91.
2. Klasser GD, Fischer DJ, Epstein JB. Burning mouth syndrome: recognition, understanding, and management. Oral Maxillofac Surg Clin North Am 2008; 20: 255-7.
3. López-Jornet P, Camacho-Alonso F, Andujar-Mateos P, Sánchez-Siles M, Gómez-Garcia F. Burning mouth syndrome: an update. Med Oral Patol Oral Cir Bucal 2010; 15: e562-8.
4. Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999; 28: 350-4.
5. Grushka M, Sessle BJ. Burning mouth syndrome. Dent Clin North Am 1991; 35: 171-84.
6. Fedele S, Fricchione G, Porter SR, Mignogna MD. Burning mouth syndrome (stomatodynia). QJM 2007; 100: 527-30.
7. Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 539.e1-13.
8. Rojo L, Silvestre FJ, Bagan JV, De Vicente T. Prevalence of psychopathology in burning mouth syndrome. A comparative study among patients with and without psychiatric disorders and controls. Oral Surg Oral Med Oral Pathol 1994; 78: 312-6.
9. López-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Burning mouth syndrome, oral parafunctions, and psychological profile in a longitudinal case study. J Eur Acad Dermatol Venereol 2009; 23: 363-5.
10. Forssell H, Jääskeläinen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002; 99: 41-7.
11. Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115: 332-7.
12. Gao J, Chen L, Zhou J, Peng J. A case-control study on etiological factors involved in patients with burning mouth syndrome. J Oral Pathol Med 2009; 38: 24-8.
13. Zakrzewska JM, Forssell H, Glenny A. Interventions for the treatment of burning mouth syndrome: a systematic review. J Orofac Pain 2003; 17: 293-300.
14. López-Jornet P, Camacho-Alonso F, Andujar-Mateos P. A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome. Oral Dis 2011; 17: 277-82.
15. Ko JY, Park IH, Park HK, Kho HS. Outcome predictors of initial treatment with topical lubricant and parafunctional habit control in burning mouth syndrome (BMS). Arch Gerontol Geriatr 2011; 53: 263-9.
16. Mínguez Serra MP, Salort Llorca C, Silvestre Donat FJ. Pharmacological treatment of burning mouth syndrome: a review and update. Med Oral Patol Oral Cir Bucal 2007; 12: E299-304.
17. Marino R, Torretta S, Capaccio P, Pignataro L, Spadari F. Different therapeutic strategies for burning mouth syndrome: preliminary data. J Oral Pathol Med 2010; 39: 611-6.
18. Grushka M, Epstein J, Mott A. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 557-61.
19. Grémeau-Richard C, Woda A, Navez ML, et al. Topical clonazepam in stomatodynia: a randomized placebo-controlled study. Pain 2004; 108: 51-7.
20. Femiano F, Gombos F, Scully C. Burning mouth syndrome: the efficacy of lipoic acid on subgroups. J Eur Acad Dermatol Venereol 2004; 18: 676-8.
21. Torgerson RR. Burning mouth syndrome. Dermatol Ther 2010; 23: 291-8.
22. Amos K, Yeoh SC, Farah CS. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study. J Orofac Pain 2011; 25: 125-30.
23. Heckmann SM, Kirchner E, Grushka M, Wichmann MG, Hummel T. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope 2012; 122: 813-6.
24. Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P. The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial. Br J Dermatol 2008; 158: 573-7.
25. Khorasani G, Hosseinimehr SJ, Azadbakht M, Zamani A, Mahdavi MR. Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study. Surg Today 2009; 39: 587-91.
26. Shelton RM. Aloe vera; its chemical and therapeutic properties. Int J Dermatol 1991; 30: 679-83.
27. Su CK, Mehta V, Ravikumar L, et al. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. Int J Radiat Oncol Biol Phys 2004; 60: 171-7.
28. Salazar-Sánchez N, López-Jornet P, Camacho-Alonso F, Sánchez-Siles M. Efficacy of topical aloe vera in patients with oral lichen planus: a randomized double-blind study. J Oral Pathol Med 2010; 39: 735-40.
29. Bjelland I, Dhal A, Huag T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 2: 69-77.
30. Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, Ughetto S, Woda A. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain 2010; 149: 27-32.
31. López-Jornet P, Camacho-Alonso F, Lucero-Berdugo M. Quality of life in patients with burning mouth syndrome. J Oral Pathol Med 2008; 37: 389-94.
32. Souza FT, Santos TP, Bernardes VF, et al. The impact of burning mouth syndrome on health-related quality of life. Health Qual Life Outcomes 2011; 9: 57.
33. Lopez R, Baelum V. Spanish version of the Oral Health Impact Profile (OHIP-Sp). BMC Oral Health 2006; 6: 1-8.
34. Axell T. Treatment of smarting symptoms in the oral mucosa by appliance of lingual acrylic splints. Swed Dent J 2008; 32: 165-9.
35. Sardella A, Lodi G, Demarosi F, Bez C, Cassano S, Carrassi A. Burning mouth Syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 2006; 12: 152-5.
36. Woda A, Navez ML, Picard P, Gremeau C, Pichard-Leandri E. A possible therapeutic solution for stomatodynia (burning mouth syndrome). J Orofac Pain 1998; 12: 272-8.
37. Sardella A, Uglietti D, Demarosi F, Lodi G, Bez C, Carrassi A. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 683-6.
38. Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol 2012; 123: 71-7.